Overview

Fasting Bioavailability Study of Lovastatin Tablets and Mevacor Tablets

Status:
Completed
Trial end date:
2004-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate and compare the relative bioavailability and therefore the bioequivalence of a test formulation of lovastatin tablets to an equivalent dose of MevacorĀ® tablets after a single oral dose administered under fasting conditions.
Phase:
Phase 1
Details
Lead Sponsor:
Mutual Pharmaceutical Company, Inc.
Treatments:
Dihydromevinolin
L 647318
Lovastatin